Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma

doi:10.3748/wjg.v29.i31.4706

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4964)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-11) series.

Item

Count

PDF

120

WORD

HTML

2580

Figures (1-3)

291

Tables (1-11)

468

Sum=3485

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

143

Download

507

Sum=650

Publishing Process of This Article

Item

Count

Browse

174

Download

459

Sum=633

Aug 21, 2023 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Aug 21, 2023; 29(31): 4706-4735
Published online Aug 21, 2023. doi: 10.3748/wjg.v29.i31.4706

Table 6 Efficacy of microRNAs used to predict the prognosis of hepatitis B virus-associated hepatocellular carcinoma

Tissues/serum	miRNA panels	Risk/protective factors	Outcome	HR	CI	Ref.
Tissues	miR-9-3^a	Risk	OS	-	-	[62]
Tissues	miR-10b^a	Risk	OS	-	-	[62]
Tissues	miR-21^b	Risk	DFS	3.019	0.219-6.939	[56]
Tissues	miR-29a-5p^b	Risk	TTR	0.5	0.3-0.8	[63]
Tissues	miR-29a-5p^b	Risk	OS	-	-	[63]
Tissues	miR-31^a	Risk	OS	-	-	[62]
Tissues	miR-106b^a	Risk	OS, DFS	-	-	[64]
Tissues	miR-122^a	Protect	OS	-	-	[54]
Tissues	miR-122^b	Protect	OS	-	-	[55]
Tissues	miR-143^b	Protect	OS	-	-	[55]
Tissues	miR-145^a	Protect	DFS	1.12	0.293-2.958	[56]
Tissues	miR-193b^c	Protect	OS	-	-	[57]
Tissues	miR-203a	Protect	OS	0.63	0.41-0.97	[58]
Tissues	miR-216b^c	Protect	OS, DFS	-	-	[59]
Tissues	miR-224^b	Risk	OS	-	-	[55]
Tissues	miR-371a-5p^b	Risk	OS	-	-	[27]
Tissues	miR-375	Protect	DFS	-	-	[60]
Tissues	miR-375^b	Protect	OS	-	-	[55]
Tissues	miR-384^a	Protect	OS	-	-	[61]
Tissues	miR-519c^a	Risk	OS	-	-	[62]
Tissues	miR-522^a	Risk	OS	-	-	[62]
Tissues	miR-522^b	Risk	OS	2.19	1.33-3.6	[65]
Tissues	miR-523^b	Risk	OS	1.5	1-2.44	[65]
Tissues	miR-3188^c	Risk	OS, DFS	-	-	[28]
Tissues	miR-3660^a	Risk	OS	-	-	[62]
Tissues	miR-3682-3p^c	Risk	OS	-	-	[66]
Tissues	miR-4784^a	Risk	OS	-	-	[62]
Tissues	miR-5188^b	Risk	OS	-	-	[67]
Tissues	miR-6883^a	Risk	OS	-	-	[62]
Serum	miR-24-3p^b	Risk	OS	2.141	1.158-3.960	[33]
Serum	miR-24-3p^b	Risk	DFS	2.055	1.114-3.792	[33]
Serum	miR-29a-3p^b	Risk	OS	4.0	1.2-13.9	[69]
Serum	miR-29a-3p^a	Risk	PFS	-	-	[69]
Serum	miR-96^a	Risk	OS	-	-	[34]
Serum	miR-150^c	Protect	OS	0.446	0.233-0.854	[13]
Serum	miR-192-5p^b	Risk	OS	-	-	[69]
Serum	miR-192-5p^b	Risk	PFS	2.2	1.1-4.2	[69]
Serum	miR-487b^a	Risk	OS	2.846	1.139-7.114	[19]
Serum	miR-487b^c	Risk	OS	2.115	1.083-4.132	[18]
Serum	miR-768-3p^b	Protect	OS	3.057	1.136-8.225	[20]
Plasma	miR-155	Risk	OS	-	-	[70]

^aP < 0.05.

^bP < 0.01.

^cP < 0.001.

OS: Overall survival; DFS: Disease-free survival; TTR: Time to tumor recurrence; PFS: Progression-free survival; HR: Hazard ratio; CI: Confidence interval; miRNAs: MicroRNAs.

Citation: Zhang MH, Yuan YF, Liu LJ, Wei YX, Yin WY, Zheng LZY, Tang YY, Lv Z, Zhu F. Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol 2023; 29(31): 4706-4735
URL: https://www.wjgnet.com/1007-9327/full/v29/i31/4706.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i31.4706